Latest Breaking News On - Virios therapeutics daily - Page 1 : comparemela.com

Virios Therapeutics (NASDAQ:VIRI) vs Exicure (NASDAQ:XCUR) Critical Contrast

Virios Therapeutics (NASDAQ:VIRI – Get Free Report) and Exicure (NASDAQ:XCUR – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Volatility and Risk Virios Therapeutics has a beta […]

United statesExicure incInnovative med conceptsVirios therapeutics incVirios therapeuticsGet free reportVirios therapeutics daily

Financial Review: Virios Therapeutics (NASDAQ:VIRI) & Exicure (NASDAQ:XCUR)

Virios Therapeutics (NASDAQ:VIRI – Get Free Report) and Exicure (NASDAQ:XCUR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends. Earnings & Valuation This table compares Virios Therapeutics […]

United statesExicure incInnovative med conceptsVirios therapeutics incVirios therapeuticsGet free reportVirios therapeutics daily

Virios Therapeutics (NASDAQ:VIRI) Issues Quarterly Earnings Results

Virios Therapeutics (NASDAQ:VIRI) Issues Quarterly Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Virios therapeutics incVirios therapeuticsGet free reportTherapeutics trading downVirios therapeutics daily

Virios Therapeutics (VIRI) Set to Announce Quarterly Earnings on Thursday

Virios Therapeutics (VIRI) Set to Announce Quarterly Earnings on Thursday
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Virios therapeutics company profileVirios therapeutics incVirios therapeuticsGet free reportVirios therapeutics daily

Virios Therapeutics, Inc (NASDAQ:VIRI) Short Interest Down 42 7% in October

Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 111,000 shares, a decrease of 42.7% from the October 15th total of 193,800 shares. Based on an average daily volume of 599,200 shares, the short-interest ratio […]

Gregory scott duncanVirios therapeutics incRenaissance technologiesVanguard group incVirios therapeutics company profileEnvestnet asset management incVirios therapeuticsGet free reportScott duncanStreet corpEnvestnet asset managementAsset managementVirios therapeutics dailyNasdaq viri